Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith L Thijs

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Immunology and Allergy Clinics of North America|November 26, 2016
Current and Future Biomarkers in Atopic DermatitisJudith L Thijs, Marjolein S de Bruin-Weller, DirkJan Hijnen
Journal of Clinical Medicine|August 5, 2015
New Developments in Biomarkers for Atopic DermatitisJudith L Thijs, Wouter van Seggelen, Carla Bruijnzeel-Koomen, et al.
Current Opinion in Allergy and Clinical Immunology|May 31, 2019
Dupilumab after the 2017 approval for the treatment of atopic dermatitis: what's new and what's next?Jorien van der Schaft, Judith L Thijs, Marjolein S de Bruin-Weller, et al.
Expert Opinion on Biological Therapy|February 16, 2019
Towards personalized treatment in atopic dermatitisJorien van der Schaft, Judith L Thijs, Floor M Garritsen, et al.
Therapeutic Advances in Chronic Disease|September 6, 2018
Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapyLieneke F M Ariëns, Daphne S Bakker, Jorien van der Schaft, et al.
The Journal of Allergy and Clinical Immunology|July 8, 2021
Unraveling heterogeneity in pediatric atopic dermatitis: Identification of serum biomarker based patient clustersDaphne S Bakker, Marlies de Graaf, Stefan Nierkens, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 22, 2013
[Allergy testing in atopic dermatitis: often unnecessary]Judith L Thijs, Roger A M J Damoiseaux, Peter Lucassen, et al.
The Journal of Allergy and Clinical Immunology|June 12, 2020
Confirmation of multiple endotypes in atopic dermatitis based on serum biomarkersDaphne S Bakker, Stefan Nierkens, Edward F Knol, et al.
Chemistry & Biology|November 10, 2015
Combinatorial Screening Identifies Novel Promiscuous Matrix Metalloproteinase Activities that Lead to Inhibition of the Therapeutic Target IL-13Carole Urbach, Nathaniel C Gordon, Ian Strickland, et al.
Acta Dermato-Venereologica|August 16, 2021
Rapid and Sustained Effect of Dupilumab on Work Productivity in Patients with Difficult-to-treat Atopic Dermatitis: Results from the Dutch BioDay RegistryLieneke F M Ariëns, Daphne S Bakker, Lotte S Spekhorst, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Immunology and Allergy Clinics of North America|November 26, 2016
Current and Future Biomarkers in Atopic DermatitisJudith L Thijs, Marjolein S de Bruin-Weller, DirkJan Hijnen
Journal of Clinical Medicine|August 5, 2015
New Developments in Biomarkers for Atopic DermatitisJudith L Thijs, Wouter van Seggelen, Carla Bruijnzeel-Koomen, et al.
Current Opinion in Allergy and Clinical Immunology|May 31, 2019
Dupilumab after the 2017 approval for the treatment of atopic dermatitis: what's new and what's next?Jorien van der Schaft, Judith L Thijs, Marjolein S de Bruin-Weller, et al.
Expert Opinion on Biological Therapy|February 16, 2019
Towards personalized treatment in atopic dermatitisJorien van der Schaft, Judith L Thijs, Floor M Garritsen, et al.
Therapeutic Advances in Chronic Disease|September 6, 2018
Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapyLieneke F M Ariëns, Daphne S Bakker, Jorien van der Schaft, et al.
The Journal of Allergy and Clinical Immunology|July 8, 2021
Unraveling heterogeneity in pediatric atopic dermatitis: Identification of serum biomarker based patient clustersDaphne S Bakker, Marlies de Graaf, Stefan Nierkens, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 22, 2013
[Allergy testing in atopic dermatitis: often unnecessary]Judith L Thijs, Roger A M J Damoiseaux, Peter Lucassen, et al.
The Journal of Allergy and Clinical Immunology|June 12, 2020
Confirmation of multiple endotypes in atopic dermatitis based on serum biomarkersDaphne S Bakker, Stefan Nierkens, Edward F Knol, et al.
Chemistry & Biology|November 10, 2015
Combinatorial Screening Identifies Novel Promiscuous Matrix Metalloproteinase Activities that Lead to Inhibition of the Therapeutic Target IL-13Carole Urbach, Nathaniel C Gordon, Ian Strickland, et al.
Acta Dermato-Venereologica|August 16, 2021
Rapid and Sustained Effect of Dupilumab on Work Productivity in Patients with Difficult-to-treat Atopic Dermatitis: Results from the Dutch BioDay RegistryLieneke F M Ariëns, Daphne S Bakker, Lotte S Spekhorst, et al.
Pageof 2